“Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology”. Clinical Science112 (8): 417–28. (April 2007). doi:10.1042/CS20060342. PMID17346243.
“The role of angiotensin II receptors in vascular regulation”. Journal of Cardiovascular Pharmacology6 Suppl 4 (Suppl 4): S575-86. (1984). doi:10.1097/00005344-198406004-00004. PMID6083400.
“The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy”. Hypertension46 (6): 1347–54. (December 2005). doi:10.1161/01.HYP.0000193504.51489.cf. PMID16286564.
“AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation”. Neuroscience137 (4): 1369–79. (2006). doi:10.1016/j.neuroscience.2005.10.051. PMID16343778.
“From angiotensin IV binding site to AT4 receptor”. Molecular and Cellular Endocrinology302 (2): 159–66. (April 2009). doi:10.1016/j.mce.2008.11.015. PMID19071192.
“Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation”. Psychopharmacology209 (4): 303–11. (May 2010). doi:10.1007/s00213-010-1791-1. PMID20224888.
“Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology”. Clinical Science112 (8): 417–28. (April 2007). doi:10.1042/CS20060342. PMID17346243.
“The role of angiotensin II receptors in vascular regulation”. Journal of Cardiovascular Pharmacology6 Suppl 4 (Suppl 4): S575-86. (1984). doi:10.1097/00005344-198406004-00004. PMID6083400.
“The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy”. Hypertension46 (6): 1347–54. (December 2005). doi:10.1161/01.HYP.0000193504.51489.cf. PMID16286564.
“AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation”. Neuroscience137 (4): 1369–79. (2006). doi:10.1016/j.neuroscience.2005.10.051. PMID16343778.
“From angiotensin IV binding site to AT4 receptor”. Molecular and Cellular Endocrinology302 (2): 159–66. (April 2009). doi:10.1016/j.mce.2008.11.015. PMID19071192.
“Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation”. Psychopharmacology209 (4): 303–11. (May 2010). doi:10.1007/s00213-010-1791-1. PMID20224888.